All Relations between Neuroleptic Malignant Syndrome and nms

Publication Sentence Publish Date Extraction Date Species
Zong-Jun Te. A rare case of prochlorperazine-induced neuroleptic malignant syndrome. The American journal of emergency medicine. 2024-04-04. PMID:38575461. neuroleptic malignant syndrome (nms) is a rare yet severe condition typically associated with antipsychotic medications. 2024-04-04 2024-04-07 Not clear
Nicole Kraaijvanger, Tim Mielo. Neuroleptic malignant syndrome after overdose of haloperidol - A case report. Toxicology reports. vol 12. 2024-04-01. PMID:38560509. the neuroleptic malignant syndrome (nms), alternatively referred to as the antipsychotic malignant syndrome, is a potentially fatal condition that is infrequently observed and is linked to the administration of antipsychotic medications. 2024-04-01 2024-04-04 Not clear
b' Onur G\\xc3\\xb6k\\xc3\\xa7en, Merve Akku\\xc5\\x9. Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556939.' neuroleptic malignant syndrome (nms), which most often occurs after the use of antipsychotics, is a rare but life-threatening condition. 2024-04-01 2024-04-03 Not clear
Anıl Alp, Melike Karaçam Doğan, Elçin Özçelik Eroğlu, Mevhibe İrem Yildiz, Şeref Can Gürel, Suzan Öze. Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556940. fever; in addition to general medical conditions such as infection, malignancy, connective tissue diseases, drug treatments, malignant hyperthermia, convulsions, it can also occur due to conditions such as neuroleptic malignant syndrome (nms), serotonin syndrome, catatonia, malignant catatonia, which are frequently encountered in psychiatry clinics. 2024-04-01 2024-04-03 Not clear
Nora Vanegas-Arroyave, Stanley N Caroff, Leslie Citrome, Jovita Crasta, Roger S McIntyre, Jonathan M Meyer, Amita Patel, J Michael Smith, Khody Farahmand, Rachel Manahan, Leslie Lundt, Samantha A Cicer. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS drugs. 2024-03-19. PMID:38502289. although rare, neuroleptic malignant syndrome (nms) is a potentially life-threatening consequence of drba exposure. 2024-03-19 2024-03-23 Not clear
Simon Farrugia, Sarah Bonello, Yanika Gatt, Martin V Balza. Atypical Neuroleptic Malignant Syndrome With Type 2 Respiratory Failure Treated With Non-invasive Ventilation. Cureus. vol 16. issue 1. 2024-02-08. PMID:38327911. neuroleptic malignant syndrome (nms) is characterized by hyperthermia, severe rigidity, and autonomic instability that is life-threatening if not treated promptly by intensive supportive care. however, there have been numerous reports of "atypical nms" where the diagnostic criteria of nms are only partially satisfied. we present a case of an elderly male who presented with atypical nms secondary to antidopaminergic drug administration which precipitated acute respiratory failure. 2024-02-08 2024-02-10 Not clear
Matthew Zabel, Rajeev Kandukur. Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk. BMJ case reports. vol 17. issue 2. 2024-02-06. PMID:38320820. atypical neuroleptic malignant syndrome (nms) was diagnosed after discrediting similar illnesses through clinical reasoning, laboratory and imaging studies. 2024-02-06 2024-02-15 Not clear
Nissar Shaikh, Adnan Saadeddi. Parkinsonism-Hyperpyrexia Syndrome in a patient undergoing upper gastrointestinal surgery: A case report. Qatar medical journal. vol 2023. issue 4. 2024-01-11. PMID:38204562. it presents similarly to neuroleptic malignant syndrome (nms) and is characterized by severe rigidity, fever, autonomic instability, and altered mental status. 2024-01-11 2024-01-13 Not clear
Jesus Ramirez-Bermudez, Miguel Restrepo-Martinez, Mariana Espinola-Nadurille, Victoria Martinez-Angeles, Juan Carlos Lopez-Hernandez, Laura E Hernandez-Vanegas, Francisco Martinez-Carrillo, Ramiro Ruiz-Garcia, Veronica Rivas-Alonso, Jose Flores-Rivera, Thomas A Polla. EXAMINING THE FEATURES OF NEUROLEPTIC MALIGNANT SYNDROME IN ANTI-NMDA RECEPTOR ENCEPHALITIS: A CASE-CONTROL STUDY. Journal of the Academy of Consultation-Liaison Psychiatry. 2023-12-27. PMID:38151160. symptomatic treatment with antipsychotics is common in early stages when psychiatric symptoms predominate, and their use has been associated with serious side effects including neuroleptic malignant syndrome (nms). 2023-12-27 2023-12-30 Not clear
César Ricardo Coimbra de Matos, Eduarda Maria da Conceição Sério Pereira Beirão, Rafael Simões Neves, António José Assunção, Rui Moreira Marque. When the fever will not stop, stop the pills! A case report. Sao Paulo medical journal = Revista paulista de medicina. vol 142. issue 3. 2023-12-06. PMID:38055420. neuroleptic malignant syndrome (nms) is a neurologic emergency potentially fatal. 2023-12-06 2023-12-10 Not clear
Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazak. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal. Cureus. vol 15. issue 10. 2023-12-01. PMID:38022067. neuroleptic malignant syndrome (nms) is a potentially fatal side effect that occurs in patients taking antipsychotics. 2023-12-01 2023-12-07 Not clear
Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, Wataru Wakabayashi, Keita Oura, Satoshi Nakao, Nanaka Ichihara, Yuka Nokura, Moe Yamashita, Kensuke Matsui, Hideyuki Tanaka, Mayuko Masuta, Ichiro Ieiri, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system. Heliyon. vol 9. issue 11. 2023-11-30. PMID:38034668. adverse events (aes) of antipsychotic drugs include neuroleptic malignant syndrome (nms), which presents complex clinical symptoms, resulting in a fatal outcome. 2023-11-30 2023-12-10 Not clear
Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazak. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal. Cureus. vol 15. issue 10. 2023-12-01. PMID:38022067. neuroleptic malignant syndrome (nms) is a potentially fatal side effect that occurs in patients taking antipsychotics. 2023-11-29 2023-12-07 Not clear
Ahmet Turan Isik, Derya Kaya, Mehmet Selman Ontan, Feyza Mutlay, Esra Ates Bulut, Fatma Sena Dost, Neziha Erken, Ali Ekrem Aydi. Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic. Clinical neuropharmacology. vol 46. issue 6. 2023-11-14. PMID:37962307. neuroleptic malignant syndrome (nms) is a life-threatening condition that occurs as an adverse reaction to antipsychotic and antiemetic agents or sudden withdrawal of dopaminergic medications. 2023-11-14 2023-11-20 Not clear
Yoji Kyotani, Jing Zhao, Kiichi Nakahira, Masanori Yoshizum. The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome. Scientific reports. vol 13. issue 1. 2023-10-30. PMID:37891209. neuroleptic malignant syndrome (nms) is a rare but serious and sometimes fatal complication in patients taking antipsychotic drugs, and its underlying mechanism still remains unclear. 2023-10-30 2023-11-08 Not clear
Autumn R Schultz, Sarina Singh, Carolyn E Linek-Rajapaksha, Heather R Goode, Adam J Fusic. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use. Clinical neuropharmacology. 2023-10-24. PMID:37874611. neuroleptic malignant syndrome (nms) is a rare life-threatening condition that providers should be cognizant of when prescribing dopamine-receptor antagonists. 2023-10-24 2023-11-08 Not clear
Ahmet Turan Isik, Derya Kaya, Mehmet Selman Ontan, Feyza Mutlay, Esra Ates Bulut, Fatma Sena Dost, Neziha Erken, Ali Ekrem Aydi. Neuroleptic Malignant Syndrome in Patients With Dementia: Experiences of A Single Memory Clinic. Clinical neuropharmacology. 2023-09-25. PMID:37747824. neuroleptic malignant syndrome (nms) is a life-threatening condition that occurs as an adverse reaction to antipsychotic and antiemetic agents or sudden withdrawal of dopaminergic medications. 2023-09-25 2023-10-07 Not clear
Adela G Buciuc, Paula Traugott, Carlos R Dange. An Unusual Presentation of Serotonin Syndrome and Subsequent Catatonia in a Patient With a Family History of Huntington's Disease. Cureus. vol 15. issue 9. 2023-09-18. PMID:37720123. neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) represent serious life-threatening conditions that share phenotypic and pathophysiologic features due to intricate interactions between the dopaminergic and serotoninergic systems. 2023-09-18 2023-10-07 Not clear
Ahmed Ali Aziz, Muhammad Ali Aziz, Rehan Sha. A Rare Case of Malignant Syndrome in Parkinson's Disease Caused by Severe Dehydration and Complicated by Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). Cureus. vol 15. issue 7. 2023-08-25. PMID:37621801. the syndrome is quite similar to neuroleptic malignant syndrome (nms) in presentation and is a potentially fatal syndrome. 2023-08-25 2023-09-07 Not clear
Jordan Virolle, Maximilien Redon, François Montastruc, Simon Taïb, Alexis Revet, Vuk Zivkovic, Julien Da Costa, Etienne Ver. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review. Schizophrenia research. 2023-08-20. PMID:37599139. antipsychotic-induced catatonia (aic) and neuroleptic malignant syndrome (nms) are life-threatening adverse reactions to antipsychotic medication. 2023-08-20 2023-09-07 Not clear